Guided Therapeutics (GTHP) Amortization of Deferred Charges (2018 - 2025)
Guided Therapeutics recorded quarterly Amortization of Deferred Charges of $55000.0 in Q4 2025, up 1.85% quarter-over-quarter from $54000.0 in Q3 2025, and up 44.74% year-over-year from $38000.0 in Q4 2024.
Guided Therapeutics' Amortization of Deferred Charges history runs 8 years deep, the most recent figure standing at $55000.0 for Q4 2025.
- In Q4 2025, Amortization of Deferred Charges rose 44.74% year-over-year to $55000.0; the TTM figure through Dec 2025 stood at $244000.0 (up 121.82% YoY), while the FY2025 annual figure was $244000.0, up 121.82% from the prior year.
- Amortization of Deferred Charges came in at $55000.0 for Q4 2025 at Guided Therapeutics, up from $54000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $172000.0 in Q2 2021 to a low of $14000.0 in Q3 2021.
- A 5-year average of $47350.0 and a median of $35000.0 in 2022 frame the typical range for Amortization of Deferred Charges.
- Across the five-year window, Amortization of Deferred Charges plunged 86.41% in 2021 and jumped 277.78% in 2025, its largest moves.
- Guided Therapeutics' Amortization of Deferred Charges stood at $70000.0 in 2021, then tumbled by 54.29% to $32000.0 in 2022, then gained by 3.12% to $33000.0 in 2023, then rose by 15.15% to $38000.0 in 2024, then soared by 44.74% to $55000.0 in 2025.
- According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $55000.0, $54000.0, and $68000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 55,000.00 |
| Dec 31, 2025 | 55,000.00 |
| Sep 30, 2025 | 54,000.00 |
| Sep 30, 2025 | 54,000.00 |
| Jun 30, 2025 | 68,000.00 |
| Jun 30, 2025 | 68,000.00 |
| Mar 31, 2025 | 67,000.00 |
| Mar 31, 2025 | 67,000.00 |
| Dec 31, 2024 | 38,000.00 |
| Dec 31, 2024 | 38,000.00 |
| Sep 30, 2024 | 22,000.00 |
| Sep 30, 2024 | 22,000.00 |
| Jun 30, 2024 | 18,000.00 |
| Jun 30, 2024 | 18,000.00 |
| Mar 31, 2024 | 32,000.00 |
| Mar 31, 2024 | 32,000.00 |
| Dec 31, 2023 | 33,000.00 |
| Dec 31, 2023 | 33,000.00 |
| Sep 30, 2023 | 32,000.00 |
| Sep 30, 2023 | 32,000.00 |
| Jun 30, 2023 | 33,000.00 |
| Jun 30, 2023 | 33,000.00 |
| Mar 31, 2023 | 32,000.00 |
| Mar 31, 2023 | 32,000.00 |
| Dec 31, 2022 | 32,000.00 |
| Dec 31, 2022 | 32,000.00 |
| Sep 30, 2022 | 33,000.00 |
| Sep 30, 2022 | 33,000.00 |
| Jun 30, 2022 | 37,000.00 |
| Jun 30, 2022 | 37,000.00 |
| Mar 31, 2022 | 41,000.00 |
| Mar 31, 2022 | 41,000.00 |
| Dec 31, 2021 | 70,000.00 |
| Dec 31, 2021 | 70,000.00 |
| Sep 30, 2021 | 14,000.00 |
| Sep 30, 2021 | 14,000.00 |
| Jun 30, 2021 | 172,000.00 |
| Jun 30, 2021 | 172,000.00 |
| Mar 31, 2021 | 64,000.00 |
| Mar 31, 2021 | 64,000.00 |
| Dec 31, 2020 | 97,000.00 |
| Dec 31, 2020 | 97,000.00 |
| Sep 30, 2020 | 103,000.00 |
| Sep 30, 2020 | 103,000.00 |
| Jun 30, 2020 | 100,000.00 |
| Jun 30, 2020 | 100,000.00 |
| Mar 31, 2020 | 94,000.00 |
| Mar 31, 2020 | 94,000.00 |
| Dec 31, 2019 | 51,000.00 |
| Dec 31, 2019 | 51,000.00 |
| Sep 30, 2019 | 8,000.00 |
| Sep 30, 2019 | 8,000.00 |
| Jun 30, 2019 | 32,000.00 |
| Jun 30, 2019 | 32,000.00 |
| Mar 31, 2019 | 14,000.00 |
| Mar 31, 2019 | 14,000.00 |
| Dec 31, 2018 | 41,000.00 |
| Dec 31, 2018 | 41,000.00 |
| Sep 30, 2018 | 53,000.00 |
| Sep 30, 2018 | 53,000.00 |
| Jun 30, 2018 | 44,000.00 |
| Jun 30, 2018 | 44,000.00 |
| Mar 31, 2018 | 52,000.00 |
| Mar 31, 2018 | 52,000.00 |